Use of Ayurvedic Swasthavritta Remedies as adjuvant in Schizophrenia patient to improve the Quality of life; A case study
DOI:
https://doi.org/10.70066/jahm.v11i2.648Keywords:
AnuTaila, Padabhyanga, Pratimarsha Nasya, Schizophrenia, Shirobhyanga, Swasthavritta, Quality of lifeAbstract
Schizophrenia affects approximately 24 million people or 1 in 300 people (0.32%) worldwide. This rate is 1 in 222 people (0.45%) among adults. Conditions that include symptoms of psychosis most commonly emerge in late adolescence or early adulthood. A 27-year-old unmarried lady suffering with Schizophrenia since 10 years, visited in OPD during month of March 2022. She was from socioeconomically upper middle class. Patient had complained of delusion of reference, delusion of persecution, thought broadcasting, Auditory hallucination, Fear, loss of interest enthusiasm in work and life, laziness, less confidence, bad dreams and disturbed sleep. PSQI, HDRS, HAM-A and WHOQOL-BREFF are used for proper mental and quality of life assessment. Active utilization of Pratimarsha Nasya (~low dose medication through nasal route) with AnuTaila, Shiroabhyanga (~therapeutic oil massage to head) with Til Taila, Padabhyanga (~ therapeutic oil massage to foot) with Til Taila, Karnapurana (~filling of ear with medicated oil) with Til Taila and Power Yoga (a fast-paced style of Yogasana without meditation) daily with proper time limit were prescribed her. Regular use of prescribed protocol for 2 months, remarkable changes in the different assessment tools and patient condition was found. Using this protocol with proper time limits in schizophrenia patient may help to improve their quality of life.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Dr Shalinee Kumari Mishra, Dr

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.